Nephrology Newswire (Page 3)

Nephrology Newswire (Page 3)

Comprehensive Real-Time News Feed for Nephrology. (Page 3)

Results 41 - 60 of 7,316 in Nephrology

  1. Developmental Origins for Kidney Disease Due to Shroom3 Deficiency.Read the original story

    Thursday Jun 14 | CiteULike

    ... GWASs that suggest a role for SHROOM3 in human kidney disease. Copyright A 2016 by the American Society of Nephrology.

    Comment?

  2. Cellular Origin and Functional Relevance of Collagen I Production in the Kidney.Read the original story

    Thursday Jun 14 | CiteULike

    ... ing on the type of disease and the underlying cause of fibrosis. Copyright 2018 by the American Society of Nephrology.

    Comment?

  3. Clinical and Pathology Findings Associate Consistently with Larger Glomerular Volume.Read the original story

    Thursday Jun 14 | CiteULike

    ... en patient populations with low and high levels of comorbidity. Copyright A 2018 by the American Society of Nephrology.

    Comment?

  4. More than 125 show up to celebrate 20th anniversary of Agarwal Renal Center in OgdensburgRead the original story

    Wednesday Jun 13 | North Country Now

    More than 125 people recently turned out to celebrate the 20th anniversary of the Dr. Ravinder N. Agarwal Renal Center. Twenty years ago, the scope of renal care in the North Country was changed forever with the opening of the Dr. Ravinder N. Agarwal Renal Center, the first free-standing renal center in the region.

    Comment?

  5. Amgen, Inc. (AMGN) Position Boosted by Old Mutual Global Investors UK Ltd.Read the original story w/Photo

    Wednesday Jun 13 | IntersportsWire

    ... It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat ...

    Comment?

  6. CrowdReviews Partnered with Conference Series to Announce: Nephrology Summit 2018Read the original story

    Wednesday Jun 13 | PR.com

    Naples, FL, June 13, 2018 -- -- Nephrology Summit 2018 cordially invites everyone to attend the Annual Congress on Nephrology & Hypertension which is held during December 06-07, 2018 at Amsterdam, Netherlands. Nephrology & Hypertension conference will assemble illustrious speakers, Researchers, Nobel laureates, Nephrologists and Urology researchers from both academic and health care professionals who will join this event to discuss their views and research.

    Comment?

  7. Salt Intake and Immunity [Brief Review]Read the original story w/Photo

    Wednesday Jun 13 | Circulation

    Department of Nephrology, Dialysis and Renal Transplant Center, "Dr C.I. Parhon" University Hospital, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania Department of Nephrology, Dialysis and Renal Transplant Center, "Dr C.I. Parhon" University Hospital, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania Renal Service, Hospital Universitario, Universidad del Zulia and Instituto Venezolano de Investigaciones CientA ficas -Zulia, Maracaibo and it has been suggested that reductions in dietary salt could substantially reduce cardiovascular events and medical costs and, therefore, should be a public health target.

    Comment?

  8. Head to Head Analysis: Apellis PharmaceuticalsRead the original story w/Photo

    Wednesday Jun 13 | AmericanBankingNews.com

    ... wet age-related macular degeneration, paroxysmal nocturnal hemoglobinuria, autoimmune hemolytic anemia, and nephrology. The company develops APL-2 for intravitreal injection that is an injection into the eye, as well as subcutaneous injection, which ...

    Comment?

  9. Sean E. Harper Sells 1,525 Shares of Amgen, Inc. (AMGN) StockRead the original story w/Photo

    Tuesday Jun 12 | Daily Political

    ... It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat ...

    Comment?

  10. Alnylam Reports Updated Positive Results from Phase 1/2 Study of...Read the original story w/Photo

    Friday Jun 8 | Drugs.com

    ... other approved treatment alternatives in place," said Prof. Bernd Hoppe, M.D., Head of the Division of Pediatric Nephrology, Department of Pediatrics, University of Bonn, Germany and an investigator in the lumasiran study. "The data presented on ...

    Comment?

  11. Dr. John R. Burton | Johns Hopkins School of MedicineRead the original story w/Photo

    Tuesday Jun 12 | Daily Record

    ... lty of Medicine. He completed his residency at Johns Hopkins Bayview Medical Center. He performed a fellowship in nephrology at Massachusetts General Hospital.

    Comment?

  12. Amgen, Inc. (AMGN) Holdings Lifted by Principal Financial Group Inc.Read the original story w/Photo

    Tuesday Jun 12 | AmericanBankingNews.com

    ... It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat ...

    Comment?

  13. Amgen, Inc. (AMGN) Holdings Boosted by Hikari Power LtdRead the original story w/Photo

    Tuesday Jun 12 | Daily Political

    ... It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat ...

    Comment?

  14. North America Renal Disease Therapeutics Market shows promising...Read the original story

    Tuesday Jun 12 | Emailwire.com

    Renal Disease Therapeutics Market, published by Market Data Forecast, the North America market is projected to reach USD 9.75 billion by 2021, at a CAGR of 5.0% from 2016 to 2021. Kidney disease, otherwise called nephropathy or renal disease is harm to or a disease of a kidney.

    Comment?

  15. Amgen, Inc. (AMGN) Shares Sold by Asset Management One Co. Ltd.Read the original story w/Photo

    Tuesday Jun 12 | AmericanBankingNews.com

    ... It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat ...

    Comment?

  16. Atal Bihari Vajpayee admitted to AIIMS: PM Modi to Rahul Gandhi, all visit to inquireRead the original story w/Photo

    Tuesday Jun 12 | The Indian Express

    ... doctors led by Dr. Guleria are part of the team conducting tests - Dr. Soumita Bagchi, assistant professor of nephrology, Dr. Shiv Kumar Choudhary, head of the cardiothoracic vascular surgery department, Dr. Naveet Wig, professor at the department ...

    Comment?

  17. Amgen (AMGN) Rating Reiterated by CannRead the original story w/Photo

    Monday Jun 11 | Daily Political

    ... It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat ...

    Comment?

  18. Drug Use Tied to Early Death, Kidney Disease ProgressionRead the original story w/Photo

    Monday Jun 11 | Drugs.com

    Among individuals with chronic kidney disease , hard illicit drug use is associated with higher risks of kidney disease progression and early death, according to a study published online June 7 in the Clinical Journal of the American Society of Nephrology . Joshua D. Bundy, Ph.D., from Tulane University in New Orleans, and colleagues used data from the 3,939 participants in the Chronic Renal Insufficiency Cohort Study to examine the associations between substance use with CKD progression and all-cause mortality among CKD patients.

    Comment?

  19. 1,404 Shares in Amgen, Inc. (AMGN) Acquired by Apriem AdvisorsRead the original story w/Photo

    Monday Jun 11 | Daily Political

    ... It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat ...

    Comment?

  20. Bayesian Capital Management LP Purchases New Holdings in Mallinckrodt PLCRead the original story w/Photo

    Monday Jun 11 | AmericanBankingNews.com

    ... pharmaceutical products for autoimmune and rare diseases in the specialty areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and ...

    Comment?